Supernus Pharmaceuticals Inc's treatment for attention deficit hyperactivity disorder met the main goal of two trials, but shares fell about 16 percent on Thursday as the data failed to convince some investors that the drug was better than rivals.


20


Reuters

Latest News

NewYorkTimes: Grace Notes: Delightful, De-Lovely and Deconstructed: Cole Porter’s Piano Is Being Rebuilt

FOX: Giuliani on whether Trump will sit down with Mueller: “Good luck -- over my dead body'

CNN: Trump's story told through classic films - Drawn by Jake Tapper

CNN: Arizona Senate drama: who will get McCain seat?

Daily Mail: More than 40 partygoers are caught with drugs at 'Festival of the Sun' music event

CBS: Jim Gaffigan: Can we please do Christmas when it's warmer?

CBS: Michael Buble on "Love"

BBC: How many comments did YouTube wipe in three months?

CTV News: Hydro to be shut off on Hamilton block after single-vehicle crash

CTV News: 'They're coming:' Flying cars may appear in urban skies by 2023

Reuters: More than 40 hurt in explosion in Japan's Sapporo: Kyodo

Jpost: More than 40 hurt in explosion in Japan's Sapporo - Kyodo

Los Angeles Times: L.A. Phil violinist Vijay Gupta is leaving the orchestra and taking his song to the streets

Los Angeles Times: Indie Focus: And the top 10 films of the year are ...

FOX: Giuliani on whether Trump will sit down with Mueller: “Good luck -- over my dead body'

Daily Mail: Video: Liam Fox says he 'could support' free vote on Brexit options

Daily Mail: Video: Teenage race car driver breaks silence over horrific airborne crash

Daily Mail: Thousands march in Brussels against U.N. migration pact

Daily Mail: Kremlin should take the lead on rap music, not shut it down says Putin

CBS: Calendar: Week of December 17

CBS: Passage: Nancy Wilson

Daily Mail: Kremlin should take the lead on rap music, not shut it down says Putin

BBC: The goalmouth scramble to end all goalmouth scrambles

19 Related Articles from 2018-12-06